CrossBay Medical

Executive Summary

CrossBay Medical is a privately held medical device company specializing in women's health, with a focus on innovative solutions for gynecological procedures. Founded in 2016 and headquartered in San Diego, California, the company has developed proprietary CrossGlide™ technology, which enables self-guided, frictionless access to the uterine cavity. This technology aims to reduce patient pain and procedural risk during common office-based gynecological interventions, such as endometrial biopsies and intrauterine device placements. The platform addresses a significant unmet need in women's health by improving patient comfort and potentially expanding access to care in outpatient settings. While the company operates in a competitive landscape, its differentiated approach could capture market share if clinical adoption and reimbursement are successfully achieved. CrossBay Medical is at a pivotal stage, seeking to commercialize its initial products and establish clinical evidence supporting its technology's benefits. The company has not disclosed funding or valuation, but its innovative catheter system targets a large addressable market. Key risks include the need for regulatory clearances, market acceptance, and competition from established players. If CrossBay can demonstrate superior clinical outcomes and secure strategic partnerships, it may become an attractive investment opportunity in the medtech space. Near-term catalysts include potential FDA 510(k) clearances and initial commercial launches.

Upcoming Catalysts (preview)

• Q4 2026FDA 510(k) Clearance for CrossGlide™ Catheter System65% success
• Q1 2027Initial Commercial Launch in U.S. Women's Health Centers50% success
• TBDStrategic Partnership or Distribution Agreement with Larger MedTech Firm40% success